Sorafenib and Sertraline: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Sertraline
No brand names on recordSorafenib
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Both sertraline (an antidepressant) and sorafenib (a cancer medicine) can each have a small effect on your heart's electrical rhythm, something called QT prolongation. When you take them together, those effects can add up and slightly raise the chance of an abnormal heartbeat.
The good news is that this concern is based on theory more than on real-world reports, and your care team can manage it. They may keep a closer eye on you, sometimes with a simple heart tracing (ECG), and decide the best combination for you. Please don't stop or change either medicine on your own. Just talk with your doctor or pharmacist about it.
Effect: Additive QT interval prolongation with potential increased risk of ventricular arrhythmias (including torsades de pointes) when sertraline and sorafenib are combined.
Mechanism: Additive pharmacodynamic effect on cardiac repolarization; both agents carry QT-prolonging potential. Neither is a prodrug, so this is a PD, not PK, interaction.
- Direction: Additive (increases arrhythmia risk)
- Severity: Major; evidence: theoretical
- Onset: Unspecified
Management: Avoid coadministration where feasible. If used together, obtain baseline and periodic ECGs, monitor and correct electrolytes (K+, Mg2+), and review other QT-prolonging drugs. Individualize therapy with the care team.
What happens
An increased risk of QT interval prolongation
Interaction Deep Dive
Concurrent use of sertraline with this medication should be avoided, since the combination can heighten the likelihood of QT prolongation and/or ventricular arrhythmias1.
Why it happens (mechanism)
Additive QT interval prolongation
How to manage this interaction
The documented advice is to avoid using these two together when possible, because the QT effects can add up.
- Keep taking both as prescribed unless your care team tells you otherwise. Do not stop either on your own.
- Your team may monitor you more closely, which can include heart tracings (ECG) and checking electrolytes like potassium and magnesium.
- They may consider an alternative medicine to lower the risk.
- Report symptoms like fainting, dizziness, palpitations, or a racing/irregular heartbeat right away.
Ask your pharmacist or prescriber whether this combination is right for you.
Management is individual — confirm any change with your pharmacist or prescriber.
Common questions
Can I take Sorafenib and Sertraline together?
Sertraline and sorafenib can each prolong the QT interval, and the makers advise avoiding the combination; if you take both, your care team may monitor your heart rhythm and electrolytes or choose an alternative. Keep taking both as prescribed and raise this with your pharmacist or doctor. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Sorafenib and Sertraline interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Sorafenib and Sertraline interaction managed?
The documented advice is to avoid using these two together when possible, because the QT effects can add up. Keep taking both as prescribed unless your care team tells you otherwise. Do not stop either on your own. Your team may monitor you more closely, which can include heart tracings (ECG) and checking electrolytes like potassium and magnesium. They may consider an alternative medicine to lower… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
From our Q&A
Real reader questions about these medications, each personally answered by our pharmacist:
Questions for your pharmacist
- Does my dose of Sorafenib or Sertraline need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (1)
- Product Information: ZOLOFT oral tablets, oral solution, sertraline hydrochloride oral tablets, oral solution. Viatris Specialty LLC (per FDA), Morgantown, WV, 2023. DailyMed
Keep reading about Sertraline
Keep reading about Sorafenib
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist